Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Health Insurance Innovations Inc    HIIQ

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Health Insurance Innovations Inc : Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Health Insurance Innovations, Inc. of Class Action Lawsuit and Upcoming Deadline - HIIQ

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/11/2017 | 10:44pm CET

NEW YORK, NY / ACCESSWIRE / October 11, 2017 / Pomerantz LLP announces that a class action lawsuit has been filed against Health Insurance Innovations, Inc. (''Health Insurance Innovations'' or the ''Company'') (NASDAQ: HIIQ) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 17-cv-06962, is on behalf of a class consisting of investors who purchased or otherwise acquired Health Insurance Innovations securities, seeking to recover compensable damages caused by defendants' violations of the Securities Exchange Act of 1934.

If you are a shareholder who purchased Health Insurance Innovations securities between August 2, 2017, and September 11, 2017, both dates inclusive, you have until November 10, 2017, to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

[Click here to join this class action]

Health Insurance Innovations operates as a developer, distributor, and administrator of cloud-based individual health and family insurance plans, and supplemental products in the United States. The Company offers, inter alia, short-term medical plans, hospital indemnity plans, and supplemental insurance products. It designs and structures individual health and family insurance plans, and supplemental products on behalf of insurance carriers and discount benefit providers and market them to individuals through a network of distributors.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Health Insurance Innovations' application for a key insurance license in its home state of Florida was rejected due to the state's Office of Insurance Regulation's (''OIR'') discovery of undisclosed legal actions against Health Insurance Innovations insiders; (ii) Health Insurance Innovations warned the OIR of the anticipated ''domino effect'' that the rejection was likely to cause, by which the Company would subsequently lose licenses in additional states; and (iii) as a result of the foregoing, Health Insurance Innovations' public statements were materially false and misleading at all relevant times.

On September 11, 2017, the website SeekingAlpha.com published an article reporting on the OIR's June 2017 rejection of Health Insurance Innovations' application for a ''key insurance license in [its] home state of Florida as [the OIR] uncovers undisclosed legal actions against HIIQ insiders'' and that ''HIIQ privately warns of disastrous ''domino effect'' spreading to other states, causing additional loss of licenses. HIIQ makes no disclosure to investors.''

On this news, Health Insurance Innovations' share price fell $6.55, or 21.91%, to close at $23.35 on September 11, 2017.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

SOURCE: Pomerantz LLP


© Accesswire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on HEALTH INSURANCE INNOVATIO
12/12 ROBBINS ARROYO LLP : Is Investigating the Officers and Directors of Health Insur..
12/11 HEALTH INSURANCE INNOVATIONS INC : Lawsuit for Investors in Shares of Health Ins..
12/08 HEALTH INSURANCE INNOVATIONS : Comerica Bank Invests $473,000 in Health Insuranc..
11/21 HEALTH INSURANCE INNOVATIONS, INC. : Change in Directors or Principal Officers (..
11/16 HEALTH INSURANCE INNOVATIONS 24 HOUR : Approximately 24 Hours Remain; ClaimsFile..
11/13 HEALTH INSURANCE INNOVATIONS INC : FINAL DEADLINE ALERT - Bronstein, Gewirtz & G..
11/10 HEALTH INSURANCE INNOVATIONS INC : FINAL DEADLINE ALERT - Bronstein, Gewirtz & G..
11/10 HIIQ REMINDER DEADLINE ALERT : The Law Offices of Howard G. Smith Reminds Invest..
11/10 HEALTH INSURANCE INNOVATIONS 24 HOUR : Approximately 24 Hours Remain; ClaimsFile..
11/08 HEALTH INSURANCE INNOVATIONS INC : Levi & Korsinsky, LLP Reminds Investors it Fi..
More news
News from SeekingAlpha
12/04 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
11/06 HEALTH INSURANCE INNOVATIONS : Fundamentals Shine
11/02 Health Insurance Innovations' (HIIQ) CEO Gavin Southwell on Q3 2017 Results -..
11/01 Health Insurance Innovations beats by $0.07, beats on revenue
10/31 Notable earnings after Wednesday?s close
Financials ($)
Sales 2017 241 M
EBIT 2017 -
Net income 2017 18,1 M
Debt 2017 -
Yield 2017 -
P/E ratio 2017 16,55
P/E ratio 2018 14,06
Capi. / Sales 2017 1,64x
Capi. / Sales 2018 1,44x
Capitalization 394 M
Chart HEALTH INSURANCE INNOVATIO
Duration : Period :
Health Insurance Innovatio Technical Analysis Chart | HIIQ | US42225K1060 | 4-Traders
Technical analysis trends HEALTH INSURANCE INNOVATIO
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 37,5 $
Spread / Average Target 58%
EPS Revisions
Managers
NameTitle
Gavin C. Southwell President, Chief Executive Officer & Director
Paul G. Gabos Non-Executive Chairman
Michael D. Hershberger CFO, Secretary, Treasurer & CAO
Sheldon X. Wang Chief Technology Officer & Director
Michael W. Kosloske Director & Chief-Product Innovation
Sector and Competitors